On January 15, 2025, the Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) issued a series of rules relating ...

On January 16, the U.S. Drug Enforcement Administration (DEA) announced three new telemedicine rules that extend prescribing flexibilities ...

Physicians would have to register with the Drug Enforcement Administration (DEA ... prescribe Schedule III-V controlled substances would need to apply for a special registration; substances ...

Now, the DEA has released a potential ... to prescribe Schedule II to V controlled substances. Providers would also have to maintain a state telemedicine registration for each state they practice ...

Healthcare providers will finally get a special registration to dispense controlled ... verification, electronic recordkeeping, and ongoing monitoring.” “We are pleased to see the DEA propose ...

For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly ...

The proposed rule for remote prescribing of controlled substances sets up a special registration process for providers based on three tiers. For all eligible providers, the DEA is proposing to ...

“Upon careful review of the DEA’s draft Special Registration for remote prescribing of controlled substances, we have serious concerns about the feasibility of this proposal,” Kyle ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.